December 18, 2025

Top 10 States to Practice Pulmonology

The following list highlights the states that offer the most favorable conditions for pulmonologists.

Conexiant

December 15, 2025

PSVT Drug Approved for First Time in Decades

A self-administered intranasal calcium channel blocker enables treatment outside emergency department settings for acute paroxysmal supraventricular tachycardia episodes.

Conexiant

December 10, 2025

Rituximab Injection Shows Promise for Mediastinitis

Direct lymph node injection combined with angioplasty improved lung function and exercise capacity in rare mediastinal condition.

Conexiant

December 10, 2025

Report Looks at the Impact of High Altitude on Healthy Males 

After moving to high altitudes above 4,300 meters, 2 previously healthy young men with normal cardiopulmonary function developed high-altitude pulmonary hypertension

Conexiant

December 10, 2025

DOACs in PE: Need for Risk Stratification

New perspective calls for dynamic, multidimensional stratification systems to address patient heterogeneity that is overlooked by standardized protocols.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant

October 30, 2024

First H5N1 Bird Flu Detected in U.S. Swine

H5N1 bird flu detected in a pig in Oregon - first case in U.S. swine; USDA assures no risk to pork supply despite spread to dairy herds & infection of 36 individuals.

Reuters

October 17, 2024

Sit or Stand: New Study Questions Workplace Advice

New study published in the International Journal of Epidemiology challenges the notion that standing reduces cardiovascular disease risk and suggests promoting overall physical activity for heart health. #CardiovascularHealth

Conexiant

May 30, 2025

Mepolizumab Reduces COPD Flares in Eosinophilic Patients

A new clinical trial found that adding mepolizumab to standard inhaled therapy significantly reduced moderate or severe COPD exacerbations in patients with high eosinophil counts, with a 21% lower annual rate and longer time to first flare.

Conexiant